Given that different microglial phenotypes, characterized by distinct gene signatures, have been identified in response to Aβ amyloid in both human and AD mouse models [47, 59, 69, 88], we also checked the expression levels of CFL1 and ACTR2 using these databases. The gene discussed is ACTR2; the disease is Alzheimer disease.